Researchers have identified significant biological connections among five distinct chronic conditions characterized by severe fatigue, potentially paving the way for improved diagnostic tools and treatments. The study examined myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome (CFS), long Covid, post-traumatic stress disorder (PTSD), rheumatoid arthritis, and multiple sclerosis (MS), which have historically been treated as separate disorders due to their distinct triggers and clinical presentations.

Led by scientists from the University of East Anglia and Oxford Biodynamics, the research focused on the three-dimensional structure of DNA within patients’ cells, rather than just their genetic sequences. This approach revealed that, despite different initiating factors—ranging from viral infections in ME and long Covid to psychological trauma in PTSD and autoimmune processes in rheumatoid arthritis and MS—the conditions share disruptions in common biological systems. These include the immune response, inflammatory signaling, mitochondrial energy production, and stress-response mechanisms.

Professor Dmitry Pshezhetskiy, who spearheaded the study, noted that patients across these illnesses frequently report similar symptoms such as overwhelming fatigue, brain fog, impaired concentration, disturbed sleep, autonomic dysfunction, and significant reductions in daily functioning. Although individual genes showed little overlap across the diseases, the complex networks formed by gene interactions suggested a shared underlying “systems failure” that manifests as chronic exhaustion.

The findings challenge previous assumptions that these conditions are unrelated and suggest they may instead represent varied expressions of a deeper malfunction within interconnected biological pathways. For example, the study proposes that ME patients might experience “worn out” immune cells, which could explain persistent symptoms even after the initial trigger, such as a viral infection, has resolved.

Published in the Journal of Translational Medicine, the research carries potential clinical implications, particularly for conditions like ME and long Covid that currently lack definitive laboratory tests and rely heavily on symptom-based diagnoses. Pshezhetskiy emphasized that the work moves closer to establishing a biological unifying theory of fatigue and could facilitate the development of objective blood tests capable of identifying specific biological signatures.

By uncovering shared molecular disruptions, the study also raises the possibility of creating treatments applicable across multiple fatigue-related conditions, potentially benefiting millions worldwide living with chronic exhaustion. While further research is needed to translate these findings into practical diagnostic and therapeutic advances, the study represents a significant step toward understanding the biological basis of fatigue across diverse chronic illnesses.